These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 32937915)
1. Cathepsin B-Responsive Liposomes for Controlled Anticancer Drug Delivery in Hep G2 Cells. Lee S; Song SJ; Lee J; Ha TH; Choi JS Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32937915 [TBL] [Abstract][Full Text] [Related]
2. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
3. Enzyme-responsive destabilization of stabilized plasmid-lipid nanoparticles as an efficient gene delivery. Song SJ; Lee S; Lee Y; Choi JS Eur J Pharm Sci; 2016 Aug; 91():20-30. PubMed ID: 27240779 [TBL] [Abstract][Full Text] [Related]
4. Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery. Lee SJ; Jeong YI; Park HK; Kang DH; Oh JS; Lee SG; Lee HC Int J Nanomedicine; 2015; 10():5489-503. PubMed ID: 26357473 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of mono- and multi-hydroxyl low toxicity pH-sensitive cationic lipids for drug delivery. Zhao Z; Yao W; Wang N; Liu C; Zhou H; Chen H; Qiao W Eur J Pharm Sci; 2019 May; 133():69-78. PubMed ID: 30914360 [TBL] [Abstract][Full Text] [Related]
6. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes. Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178 [TBL] [Abstract][Full Text] [Related]
7. Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge. Dadashzadeh S; Mirahmadi N; Babaei MH; Vali AM J Control Release; 2010 Dec; 148(2):177-86. PubMed ID: 20800629 [TBL] [Abstract][Full Text] [Related]
8. Effective Remote Loading of Doxorubicin into DPPC/Poloxamer 188 Hybrid Liposome to Retain Thermosensitive Property and the Assessment of Carrier-Based Acute Cytotoxicity for Pulmonary Administration. Tagami T; Kubota M; Ozeki T J Pharm Sci; 2015 Nov; 104(11):3824-3832. PubMed ID: 26228287 [TBL] [Abstract][Full Text] [Related]
9. Modulation of doxorubicin resistance in multidrug-resistance cells by targeted liposomes combined with hyperthermia. Gaber MH J Biochem Mol Biol Biophys; 2002 Oct; 6(5):309-14. PubMed ID: 12385965 [TBL] [Abstract][Full Text] [Related]
10. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect. Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017 [TBL] [Abstract][Full Text] [Related]
11. Cell-penetrating Peptide-coated Liposomes for Drug Delivery Across the Blood-Brain Barrier. Yuan BO; Zhao Y; Dong S; Sun Y; Hao F; Xie J; Teng L; Lee RJ; Fu Y; Bi YE Anticancer Res; 2019 Jan; 39(1):237-243. PubMed ID: 30591464 [TBL] [Abstract][Full Text] [Related]
12. Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers. Boakye CH; Patel K; Singh M Int J Pharm; 2015 Jul; 489(1-2):106-16. PubMed ID: 25910414 [TBL] [Abstract][Full Text] [Related]
13. Enzyme-Responsive Amphiphilic Peptide Nanoparticles for Biocompatible and Efficient Drug Delivery. Song SJ; Choi JS Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057039 [TBL] [Abstract][Full Text] [Related]
14. Encapsulation enhancement and stabilization of insulin in cationic liposomes. Park SJ; Choi SG; Davaa E; Park JS Int J Pharm; 2011 Aug; 415(1-2):267-72. PubMed ID: 21645598 [TBL] [Abstract][Full Text] [Related]
15. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery. Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641 [TBL] [Abstract][Full Text] [Related]
16. Heparosan-coated liposomes for drug delivery. Lane RS; Haller FM; Chavaroche AAE; Almond A; DeAngelis PL Glycobiology; 2017 Nov; 27(11):1062-1074. PubMed ID: 29044377 [TBL] [Abstract][Full Text] [Related]
17. Derma roller® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect. Ahmed KS; Shan X; Mao J; Qiu L; Chen J Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1448-1458. PubMed ID: 30889679 [TBL] [Abstract][Full Text] [Related]
18. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity. Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018 [TBL] [Abstract][Full Text] [Related]
19. Lipoic acid-derived cross-linked liposomes for reduction-responsive delivery of anticancer drug. Ling L; Ismail M; Du Y; Yao C; Li X Int J Pharm; 2019 Apr; 560():246-260. PubMed ID: 30769133 [TBL] [Abstract][Full Text] [Related]
20. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery. He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]